Business Wire

PSG Equity Holds Final Close of Third European Fund at Over €4.4 Billion

15.9.2026 09:00:00 EEST | Business Wire | Press release

Share

PSG Equity (“PSG”), a leading growth equity firm that specializes in partnering with software and technology-enabled services companies to drive transformational growth, today announced the final close of PSG Europe III (“PSGE III” or the “fund”) at over €4.4 billion in total committed capital. The fund reached its hard cap, receiving strong support from new and returning investors.

PSGE III surpasses its €2.6 billion predecessor fund, which held its final close in October 2023. The Europe-focused fund saw commitments from state pension funds, sovereign wealth funds, insurance companies, family offices and high net worth individuals.

PSGE III will continue the firm’s strategy of partnering with ambitious European software and technology companies, helping them to scale up as they seek to become pan-European category leaders with global reach. The fund aims to support businesses that are harnessing AI to redefine enterprise software and the next generation of AI-native companies, with recent investments made by PSG in Europe in Mistral AI, BrightAnalytics, Aikido Security, Quality Hosting, Emotion Mobility, Namirial and Glasswall.

PSG sees Europe entering a new phase of software innovation, driven by AI adoption, increasing demand for trusted European technology providers and a focus on digital sovereignty. PSG believes these structural trends are creating strong opportunities for software providers that combine deep business domain expertise with European-first infrastructure, proprietary data capabilities, and which are also able to benefit from the significant tailwinds created by AI.

PSG’s European team was established in 2019 and consists of 83 professionals, including investors and software and technology functional experts dedicated to working alongside portfolio company management teams. The team is headquartered in London with an additional office in Paris.

To date, PSG has made 43 platform investments in Europe, had 12 realization events and completed 98 add-on acquisitions with operations in 24 European cities. This includes recent exits from Sellsy, Signaturit, N2F, Artur’in, Hornetsecurity and Mapal.

Peter Wilde, Chairman of PSG, said: “We are delighted by the strong support PSGE III has received from both long-standing and new investors globally. This outcome underscores the strength of PSG’s global platform and our consistent, disciplined approach to creating value, with a focus on supporting high growth software companies with the capital and operational resources needed to build enduring category leaders.”

Mark Hastings, Chief Executive Officer of PSG, said: “It’s an exciting time to partner with leading software scale-ups in Europe. We see AI materially expanding the enterprise software opportunity, creating the next generation of category leaders while accelerating innovation across established software platforms. We are excited to continue to support AI-native businesses with differentiated technology and clear competitive advantages, while helping mission critical systems of record and infrastructure harness AI to enhance their products, accelerate innovation and drive growth.”

Dany Rammal, Managing Director and Head of Europe at PSG, added: “The close of PSGE III marks an important milestone for PSG Equity and reflects our conviction in the vibrant European software and technology ecosystem. We see Europe accelerating its pace of producing exceptional software and AI businesses. Our platform allows us to identify what we believe are some of the best businesses across the region and partner with founders and management teams as they build pan-European market leaders with global reach. As digital sovereignty has become increasingly important for customers, we believe Europe has a real opportunity to create competitive software champions at scale.”

About PSG
PSG Equity is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities and build strong teams. Having backed more than 170+ companies and facilitated over 550+ add-on acquisitions, PSG Equity brings extensive investment experience, deep expertise in software and technology and a firm commitment to collaborating with management teams. Founded in 2014, PSG Equity operates out of offices in Boston, London and Paris. To learn more about PSG Equity, visit www.psgequity.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260914743320/en/

Contacts

Media Contact
Matthieu Roussellier/Kate Pledger
pro-psg@prosek.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Reports Third Quarter 2026 Results3.11.2026 23:30:00 EET | Press release

IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2026. Results are presented on a continuing operations basis, excluding the Food Ingredients business and other minor perimeter adjustments (the “Food Ingredients disposal group”), and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”). The Food Ingredients disposal group and the SCL disposal group are reported as discontinued operations. Management Commentary “IFF delivered a solid third quarter, with improved sales and profitability across all divisions,” said Erik Fyrwald, CEO of IFF. “Taste and Scent delivered strong top- and bottom-line results, and Health & Biosciences improved modestly as we continue to strengthen the business. We also generated strong cash flow through the first nine months of 2026 and recently completed our $500 million accelerated share repurchase program. The separation of Food Ingredients is progressing well, and we are on track with our timelin

2026–2027 World Branding Awards Honours Global “ Brand of the Year ” Winners at Hampton Court Palace3.11.2026 22:00:00 EET | Press release

The World Branding Awards returned to honour the brands that continue to set the benchmark for excellence. The 2026–2027 World Branding Awards Ceremony took place at the iconic Hampton Court Palace, marking the 21st edition of the awards. Set within the grandeur of a historic venue, the prestigious event brought together guests from across the globe for a memorable celebration. The evening was hosted by the acclaimed BBC presenter, Hannah Gray, and was further enriched by a keynote presentation from renowned speaker Adrian Webster. Earning a World Branding Awards remains a highly distinguished achievement. Winners are determined through a rigorous evaluation process encompassing brand valuation, consumer market research, and public online voting. This year, over 105,000 consumers took part in the voting process, and more than 2,000 brands from 62 countries were nominated. Of these, less than 10 brands from each country were declared the “Brand of the Year” across the Global, Regional,

Gencom Acquires Rosewood London, Expanding Its Footprint With Its First Luxury Hotel Acquisition in Europe3.11.2026 20:05:00 EET | Press release

Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London, the landmark 308-key luxury hotel situated at 252 High Holborn in Central London. The acquisition strengthens Gencom’s global hospitality investment platform and expands its presence in Europe through its first luxury hotel asset in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103137897/en/ Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London in Central London London is one of the world’s most supply-constrained hospitality markets, supported by year-round demand from both leisure and business travelers. The acquisition of Rosewood London reflects Gencom’s conviction in the market and serves as a strategic entry point into Europe. The transaction further enhances the firm’s assemblage

SGCA Honours Communication Excellence Across Asia, Europe and the Arab World3.11.2026 17:52:00 EET | Press release

His Highness Sheikh Dr Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, honoured winners of the 13th Sharjah Government Communication Award (SGCA), organised by the Sharjah Government Media Bureau (SGMB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103972039/en/ SGCA honours communication excellence across Asia, Europe and the Arab world (Photo: AETOSWire) Winners represented China, India, Thailand, Ukraine and the Arab world. Some 433 entries from 31 countries across four continents passed initial screening. The award covered 23 categories across five sectors, including six partner awards. His Excellency Tariq Saeed Allay, Director General of SGMB, highlighted the award’s growth under the vision of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, noting that it had attracted more than 9,500 entries over five year

BioLife to Showcase Oral Peptide Delivery Technology During London Life Sciences Week3.11.2026 17:03:00 EET | Press release

BioLife Products Limited today announced its participation in London Life Sciences Week, where it will highlight its patented oral peptide delivery technology and recent advances in its intellectual property portfolio. BioLife will present at the LSX Investival Showcase on Monday, November 16, 2026, from 3:15 to 3:30 p.m. GMT, at Old Billingsgate, London. The presentation will be led by Former US Ambassador James P. Cain, Strategic Advisor to the Chairman & Founder, alongside Ludivine Delattre, Business and Corporate Relations, and will highlight the scientific journey behind the technology and its potential applications. BioLife is focused on developing a novel approach to delivering peptide therapeutics orally. Built on over 35 years of pharmaceutical effervescence expertise and two decades of oral peptide research by founder and inventor Dr. Farid Bennis, the technology uses a dissolvable effervescent tablet to create a buffered solution that helps protect peptides during gastrointe

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye